Anacor Pharma (ANAC) Tops Q1 EPS by 19c

Anacor Pharma (NASDAQ: ANAC) reported Q1 EPS of ($0.30), $0.19 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $15.26 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on Anacor Pharma (ANAC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• Taylor Devices (TAYD) Misses Q4 EPS by 31c